The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders. A new trial is planned to compare Therabot's results with conventional therapies. The medical establishment appears receptive to such innovation.
from Tech-Economic Times https://ift.tt/DaQOtlw
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
The Devas shareholders are enforcing an International Chamber of Commerce arbitral award of $1.2 billion to Devas, owed by ISRO commercial a...
No comments:
Post a Comment